Cell separation technologies market seen reaching $22.2 billion by 2030

The cell separation technologies market is forecast to grow from $11.5 billion in 2025 to $22.2 billion by 2030, driven by demand from personalized medicine, cell-based therapies and automated lab workflows. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Cell separation technologies are central to biomedical research, clinical diagnostics and treatment development because they isolate specific cell types from mixed samples. - Market growth reflects rising demand for tools used in cancer, immune and stem cell research, plus broader adoption in therapeutic development. - The forecast suggests continued investment in lab automation, high-throughput processing and AI-assisted sorting.

What happened: - The Business Research Company released its "The Cell Separation Technologies Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035." - The report says the market will grow from $11.5 billion in 2025 to $13.11 billion in 2026. - The report projects the market will reach $22.2 billion by 2030. - The forecast implies a 14.1% CAGR from 2026 to 2030. - The release includes links to a free sample of the report and the full market report.

The details: - Historical growth came from increased stem cell research, wider use of cell-based assays, expansion of biomedical and academic research institutions, higher adoption of flow cytometry and more advanced separation consumables. - Future growth is expected to come from personalized medicine research, investment in cell-based therapies, automated laboratory workflows, reproducibility needs in cell analysis and AI-assisted cell sorting. - Key trends include high-purity cell isolation methods, magnetic and fluorescence-based sorting systems, automated separation instruments, application-specific separation kits and higher-throughput processing. - Cell separation technologies are used to extract target cell types from heterogeneous mixtures for further analysis or therapeutic use. - The technologies support work involving cancer cells, immune cells and stem cells. - Chronic disease prevalence is a major demand driver because these conditions often require ongoing care and improved treatment tools. - CDC data released in April 2025 showed about 194 million U.S. adults, or 76.4%, had at least one chronic condition in 2023. - That CDC data showed prevalence at 59.5% for young adults, 78.4% for midlife adults and 93.0% for older adults.

Between the lines: - The market outlook points to a shift from manual separation toward more automated, standardized and data-driven workflows. - Demand for reproducibility and higher purity suggests buyers are prioritizing consistency and downstream research quality, not just throughput. - North America led the market in 2025, while Asia-Pacific is projected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables.

What's next: - Adoption should continue shifting toward automated instruments and application-specific kits as laboratories scale cell analysis workflows. - Cell-based therapy research and personalized medicine programs are likely to remain major demand drivers through 2030. - The company's report suggests regional growth leadership will broaden beyond North America as Asia-Pacific accelerates.

The bottom line: - Cell separation technologies are moving from a specialist research tool to a broader platform for diagnostics and therapeutic development, and the market is projected to nearly double by 2030.